4.4 Review

Minireview: Animal model of schizophrenia from the perspective of behavioral pharmacology: Effect of treatment on cognitive functions

Related references

Note: Only part of the references are listed.
Article Psychiatry

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

Robert A. McCutcheon et al.

WORLD PSYCHIATRY (2020)

Review Behavioral Sciences

The role of norepinephrine in the pathophysiology of schizophrenia

Veronica Maki-Marttunen et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)

Review Neurosciences

NMDAR Hypofunction Animal Models of Schizophrenia

Gloria Lee et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Review Neurosciences

Noradrenergic Modulation of Cognition in Health and Disease

Olga Borodovitsyna et al.

NEURAL PLASTICITY (2017)

Article Neurosciences

Differential Effects of Olanzapine and Haloperidol on MK-801-induced Memory Impairment in Mice

Jae Chun Song et al.

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2016)

Review Neurosciences

THE SEROTONERGIC SYSTEM AND COGNITIVE FUNCTION

Dubravka Svob Strac et al.

TRANSLATIONAL NEUROSCIENCE (2016)

Review Neurosciences

Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative

Alfredo Meneses

REVIEWS IN THE NEUROSCIENCES (2014)

Article Behavioral Sciences

The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat

Lukas Rambousek et al.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)

Article Psychiatry

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

Hitoshi Sakurai et al.

SCHIZOPHRENIA BULLETIN (2013)

Review Neurosciences

Dopamine, cognitive function, and gamma oscillations: role of D4 receptors

Katrina E. Furth et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2013)

Review Neurosciences

NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia

Melissa A. Snyder et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2013)

Article Medicine, Research & Experimental

5-HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

Julie Meffre et al.

EMBO MOLECULAR MEDICINE (2012)

Article Psychiatry

Spatial memory deficits in a virtual reality eight-arm radial maze in schizophrenia

Elena A. Spieker et al.

SCHIZOPHRENIA RESEARCH (2012)

Article Cell Biology

NMDA Receptor-Dependent Long-Term Potentiation and Long-Term Depression (LTP/LTD)

Christian Luescher et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)

Article Pharmacology & Pharmacy

Effects of Risperidone on Learning and Memory in Naive and MK-801-Treated Rats

Ipek Komsuoglu Celikyurt et al.

PHARMACOLOGY (2011)

Article Clinical Neurology

The effect of a full agonist/antagonist of the D1 receptor on locomotor activity, sensorimotor gating and cognitive function in dizocilpine-treated rats

Vera Bubenikova-Valesova et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat

B. Marcos et al.

BRITISH JOURNAL OF PHARMACOLOGY (2008)

Review Behavioral Sciences

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

Vera Bubenikova-Valesova et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)

Article Multidisciplinary Sciences

Risperidone and ritanserin but not haloperidol block effect of dizocilpine on the active allothetic place avoidance task

Vera Bubenikova-Valesova et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Neurosciences

The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801

Vera Bubenikova-Valesova et al.

NEUROPHARMACOLOGY (2007)

Review Clinical Neurology

Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice

Yue Hou et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)

Article Pharmacology & Pharmacy

Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment

Michael Didriksen et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2006)

Review Clinical Neurology

(+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia

JP Rung et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)

Article Behavioral Sciences

The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating

V Bubeníková et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)

Article Neurosciences

Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice

JH Wu et al.

PSYCHOPHARMACOLOGY (2005)

Article Biochemistry & Molecular Biology

D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain

YL Hurd et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2001)

Article Behavioral Sciences

Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats

T Bast et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)